{"id":7629,"date":"2026-07-21T10:21:48","date_gmt":"2026-07-21T06:21:48","guid":{"rendered":"https:\/\/urpspharma.re\/?p=7629"},"modified":"2026-07-21T10:21:49","modified_gmt":"2026-07-21T06:21:49","slug":"congres-addictologie-et-douleur-2026","status":"publish","type":"post","link":"https:\/\/urpspharma.re\/?p=7629","title":{"rendered":"Congr\u00e8s Addictologie et douleur 2026"},"content":{"rendered":"\n

2 – 3 – 4 d\u00e9cembre 2026<\/h3>\n\n\n\n

2\u00e8mes journ\u00e9es de l’Oc\u00e9an Indien<\/h2>\n\n\n\n

Cette 2e \u00e9dition poursuivra l\u2019exploration des liens complexes entre souffrance et d\u00e9pendance dans les territoires de l\u2019Oc\u00e9an Indien. Il mettra en lumi\u00e8re le cycle vicieux entre douleur physique ou psychique et usage de substances psychoactives. Les enjeux sociaux, m\u00e9dicaux et \u00e9thiques de cette double probl\u00e9matique seront au c\u0153ur des \u00e9changes. L\u2019\u00e9v\u00e9nement visera \u00e0 repenser les approches th\u00e9rapeutiques et \u00e0 promouvoir des alternatives non addictives. Une attention particuli\u00e8re sera port\u00e9e \u00e0 la lutte contre la stigmatisation et \u00e0 l\u2019accompagnement des personnes vuln\u00e9rables.<\/p>\n\n\n\n

L\u2019inscription aux 3 jours du congr\u00e8s est gratuite.<\/strong>\u00a0Seul les d\u00e9jeuners sont payants au tarif de 10\u20ac par jour.<\/p>\n\n\n\n

>> Programme en cliquant ICI<\/a><\/p>\n\n\n\n

\n
\u25ba\u00a0Cliquez ICI pour l’INSCRIPTION<\/mark><\/a><\/div>\n<\/div>\n\n\n\n
\n
\"\"<\/figure>\n\n\n\n
\"\"<\/figure>\n<\/figure>\n\n\n\n

>> Communiqu\u00e9 de presse en cliquant ICI<\/a><\/p>\n\n\n\n

\n
<\/div>\n<\/div>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

2 – 3 – 4 d\u00e9cembre 2026 2\u00e8mes journ\u00e9es de l’Oc\u00e9an Indien Cette 2e \u00e9dition poursuivra l\u2019exploration des liens complexes entre souffrance et d\u00e9pendance dans les territoires de l\u2019Oc\u00e9an Indien. Il mettra en lumi\u00e8re le cycle vicieux entre douleur physique ou psychique et usage de substances psychoactives. Les enjeux sociaux, m\u00e9dicaux et \u00e9thiques de cette…<\/p>\n","protected":false},"author":3,"featured_media":7631,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[182,262],"tags":[897,239],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/urpspharma.re\/index.php?rest_route=\/wp\/v2\/posts\/7629"}],"collection":[{"href":"https:\/\/urpspharma.re\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/urpspharma.re\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/urpspharma.re\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/urpspharma.re\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7629"}],"version-history":[{"count":1,"href":"https:\/\/urpspharma.re\/index.php?rest_route=\/wp\/v2\/posts\/7629\/revisions"}],"predecessor-version":[{"id":7633,"href":"https:\/\/urpspharma.re\/index.php?rest_route=\/wp\/v2\/posts\/7629\/revisions\/7633"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/urpspharma.re\/index.php?rest_route=\/wp\/v2\/media\/7631"}],"wp:attachment":[{"href":"https:\/\/urpspharma.re\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7629"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/urpspharma.re\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7629"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/urpspharma.re\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7629"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}